NIPH Clinical Trials Search

UMIN ID: UMIN000002331

Registered date:17/08/2009

Comparison of hypercalcemia between lanthanum carbonate and calcium carbonate in hyperphosphatemia patients on dialysis; a cross-over study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMaintenance hemodialysis patients with hyperphosphatemia
Date of first enrollment2009/08/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Lanthanum carbonatet to Calcium carbonate Calcium carbonate to Lanthanum carbonate


Primary OutcomeThe incidence of hypercalcemia for 3 months between lanthanum carbonate and calcium carbonate treatments.
Secondary Outcome1. Serum phosphate, serum calcium and serum albumin 2. Adverse events 3. Inflammation markets

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Pts with cancer or suspicious for cancer, Pts with inflammatory disorder 2) Pts who meet the contraindiation criteria in package insert of lanthanum carbonate or calcium carbonate 3) Pregnant or possibly pregnant pts, pts on lactation 4) Inappropriate pts for this study according to the investigator's judgment

Related Information


public contact
Name Tatsunori toida
Address Japan
Telephone 0982527111
Affiliation Chiyoda Hospital Internal medicine
scientific contact
Name Shouichi Fujimoto
Address 5200 Kihara Kiyotake Miyazaki Japan
Affiliation University of Miyazaki hospital Dialysis Division